RT @uFluidix: Research article: Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer -- http…
がん免疫薬で唯一確率しているバイオマーカーは腫瘍部位のがん細胞や免疫細胞におけるPD-L1検査だが、血中のがん細胞でもできるのではという報告。データをみると良さそうに見えるがPD-L1抗体がSP142と分かってがっかり。がん細胞をしっかり染めるの使ってほしい。。 https://t.co/mN4HMGjOvJ
Research article: Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer -- https://t.co/rwxCsEU575 @BioEngUCLA @dgsomucla @UCLAJCCC @cnsiatucla #microfluidics #lungcancer #cancer #metastasis #LabOnAChip http
Evaluation of PD-L1 Expression on Vortex-Isolated Circulating Tumor Cells in Metastatic Lung Cancer https://t.co/C4jje2UopC
Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer #PrecisionMedicine https://t.co/GbSshrNgrO
@NetScientific portfolio company @VortexBioSci announced the publication of a peer reviewed report which describes the use of Vortex's technology in #lungcancer in @SciReports https://t.co/bBbixkzkd7 https://t.co/Bchsw59KFy
@VortexBioSci, one of our core portfolio companies, today announced yet another publication in @SciReports which describes the potential of Vortex technology in #personalisedmedicine for lung #cancer patients. Read the full report here: https://t.co/dU1Dat